| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Lee Kalowski | CFO and President | 2025-08-26 | 4,240 | $1.80 | $7.64kSell |
| Jodie Pope Morrison | CEO | 2025-08-26 | 10,494 | $1.80 | $18.90kSell |
| Shelia M. Violette | Chief Scientific Officer | 2025-08-26 | 2,990 | $1.80 | $5.38kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Arch Venture Fund VIII LP | 47.29% | 5,768,694 | $15.29M | Insider |
| James E. Flynn | 33.51% | 4,087,305 | $10.83M | Insider |
| Orbimed Advisors LLC | 18.47% | 2,252,987 | $5.97M | Insider |
| Diyong Xu | 18.47% | 2,252,987 | $5.97M | Insider |
| Orbimed Advisors LLC | 18.47% | 2,252,987 | $5.97M | Institution |
| David S. Grayzel | 17.15% | 2,092,106 | $5.54M | Insider |
| Atlas Venture Fund X LP | 17.15% | 2,092,106 | $5.54M | Insider |
| Atlas Venture Life Science Advisors LLC | 17.15% | 2,092,106 | $5.54M | Institution |
| Carlyle Group Inc | 9.04% | 1,102,741 | $2.92M | Institution |
| Mahendra Shah | 7.46% | 909,742 | $2.41M | Insider |